ASXL1 and chronic myelomonocytic leukemia: The molecular fingerprint for CMML combines recurrent mutations in approximately 40 genes, some of which are associated with poor outcomes (ASXL1, NRAS, RUNX1, and SETBP1), and are incorporated into CMML-specific prognostic scoring systems8–10.